InvestorsHub Logo

Venture_Cap

04/30/20 4:08 PM

#72719 RE: justdafactss #72715

Yep. They’d rather take Gilead money. I get it, no worries. I have a feeling they’ll be embarrassed rather soon if Leronlimab and Remdesivir aren’t in a combo standard of care.

Hard to argue with Gilead poor data. Leronlimab has the data in their favor.